Authors
Latest:
Racial Discrimination in Cancer Care Setting Impacts Black Patients Long-TermBlack patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.
Latest:
Abrocitinib for Atopic DermatitisThe drug’s approval was based on the results of 3 clinical trials.
Latest:
Q&A: Pharmacist Prescribed Contraception Can Mitigate Barriers to CareA conversation with Ginger Lemay, PharmD, Jeffrey Bratberg, PharmD, and Audrey Whalen, PharmD.
Latest:
Don’t Get Caught Up With a HIPAA ViolationSometimes, breaches in information are the result of a simple mistake. How can those be avoided?
Latest:
Review of FDA Approvals for Pediatric Obesity ManagementGLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Latest:
Q&A: Challenges Health Systems May Face When Integrating BiosimilarsA conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.
Latest:
How Rare Cannabinoids Are Disrupting the Pharmaceutical IndustryBy 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
Latest:
FDA Issues EUA for First Oral Antiviral Pill for COVID-19The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.
Latest:
NDA for Investigational Schizophrenia Treatment Submitted to FDAThe NDA was submitted for investigational muscarinic antipsychotic, KarXT (xanomeline-trospium), which functions as a dual M1/M4 muscarinic acetylcholine receptor agonist within the central nervous system.
Latest:
How LucyRx is Changing the Traditional PBM ModelLucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
Latest:
Review: Harmful Excipients for Pediatric PatientsEvidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Latest:
Pharmacy Technicians Provide Patient Assistance With Oral OncolyticsPharmacy technicians can provide a great amount of value for patients navigating the financial toxicity of cancer treatment.
Latest:
Blood-Based Test Demonstrates High Sensitivity for Colorectal CancerA blood-based cell-free DNA (cfDNA) test was able to find patients at increased risk of colorectal cancer (CRC), advanced neoplasia, and advanced precancerous lesions.
Latest:
Protecting Our Most Vulnerable Through VaccinationFor more than 70 years, vaccination has been a public health strategy for disease mitigation. Even in populations often considered “vulnerable”—children and pregnant women—vaccination is strongly recommended and commonly embraced.
Latest:
Reevaluating the Use of Guaifenesin in the Management of Acute Cough Associated With the Common ColdDespite its popularity and its status as an FDA-approved expectorant, evidence to support guaifenesin’s efficacy is limited and conflicting.
Latest:
New Advances in Breast Cancer TherapyBreast cancer continues to affect women globally, with approximately 13% developing invasive disease. New treatment regimens and options are on the horizon for breast cancer therapy.
Latest:
Two Eye Diseases Could Contribute to Common Blinding Eye ConditionThe study could lead to early diagnosis and treatment of age-related macular degeneration.
Latest:
Preventing Severe Respiratory Infections in ChildrenA refresher on best interventions for common respiratory disorders in children.
Latest:
Focus on DIR Fees: 3 Ways to Manage ThemWhen investing in the future profitability of your pharmacy, here are 3 ways to help manage and mitigate the bottom line impacts of DIR fees.
Latest:
Maximizing Adherence Packaging for Patient Health and Pharmacy GrowthIs adherence packaging technology a big investment for a community or independent pharmacy?
Latest:
OTC Drug Interaction Considerations in the Cough and Cold AisleOTC remedies are widely available, but some carry drug-drug or drug-disease interactions that pharmacists should be aware of.
Latest:
Focus on What Matters: Sustaining Your Pharmacy in 2025What are some key strategies for keeping your pharmacy thriving in 2025?
Latest:
Navigating Pediatric ADHD Medication ShortagesStimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Latest:
Efficacy Outcomes of Some Cancer Biosimilars Indistinguishable Vs Reference ProductFindings from a systematic review found little difference in outcomes between biosimilar and reference product treatment options.
Latest:
Case Study: Treating Infants for Cannabis ExposureAs more and more states legalize recreational marijuana, caregivers need to be vigilant about keeping products out of the reach of children.
Latest:
Cannabinoid Hyperemesis Syndrome: Diagnosis and ManagementA deep dive for pharmacists into this frequently debilitating disorder
Latest:
Pharmacists Discuss Their Hopes for the Future of Pharmacy in 2025 | APhA 2025Experts discuss the evolving landscape of pharmacy through technological advancements, professional development, and advocacy.
Latest:
Creating A Successful Social Media PresenceSocial media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.
